News, Analysis & Insights on Nutrition, Supplements, and Health
The Food and Drug Administration is seeking a permanent injunction against James G. Cole Inc., an Oregon-based dietary supplement manufacturer. As is usually the case with such injunctions, the action is the culmination of a long interaction between FDA...
Mulberry is the latest ingredient to benefit from a Dr Oz mention. Since the ingredient was featured on the show on Sept. 27, demand for all things mulberry has spiked in the US, a supplier reports.
Cosmetics companies are getting their protein from an unexpected source, according to a report by the LA Times.
Pharmachem Laboratories, Inc., has acquired Utah-based Powder Processors, Inc., a move which complements the company’s overall business in particle engineering.
Australia and New Zealand have jointly issued a warning against pre-workout sports supplement OxyElite Pro following its links to an outbreak of acute non-viral hepatitis in Hawaii that killed one person and affected 29.
Glanbia Nutritionals has launched a new flax protein powder for protein fortification for use in a range of applications including bars, clusters, cereals and beverages.
Scientific backing is to have a big say in the future growth of the anti-ageing arena as manufacturers look to meet more consumers and create a feeling of trust, according to Datamonitor International Consumer Insights analyst Daniel Bone.
In the wake of some Western countries like Britain capping sales of traditional medicine imports from China, the country is now ramping up efforts to standardise production in the segment.
VPX Sports is hoping to meet growing demand for muscle recovery solutions from physically active consumers, as well as those “looking to look like the World’s Strongest Man”, through the relaunch of its ready-to-drink (RTD) Protein Rush! shake.
Chr Hansen CEO Cees de Jong today praised the Danish enzymes, cultures and colours specialist’s 2012-2013 performance that saw revenues grow 6% to €738m for the year, and highlighted 5% growth in sluggish EMEA as a major achievement.
A multiyear clinical trial backed by the US National Institute of Health (NIH) will examine whether vitamin D supplementation can help to prevent or delay the onset of diabetes.